ATE155133T1 - Piperazinderivate als 5-ht antagonisten - Google Patents
Piperazinderivate als 5-ht antagonistenInfo
- Publication number
- ATE155133T1 ATE155133T1 AT94902964T AT94902964T ATE155133T1 AT E155133 T1 ATE155133 T1 AT E155133T1 AT 94902964 T AT94902964 T AT 94902964T AT 94902964 T AT94902964 T AT 94902964T AT E155133 T1 ATE155133 T1 AT E155133T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- date
- antagonists
- piperazine derivatives
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939300194A GB9300194D0 (en) | 1993-01-06 | 1993-01-06 | Piperazine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE155133T1 true ATE155133T1 (de) | 1997-07-15 |
Family
ID=10728386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94902964T ATE155133T1 (de) | 1993-01-06 | 1993-12-24 | Piperazinderivate als 5-ht antagonisten |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5622951A (de) |
| EP (1) | EP0677046B1 (de) |
| JP (1) | JPH08505381A (de) |
| AT (1) | ATE155133T1 (de) |
| AU (1) | AU5711594A (de) |
| DE (1) | DE69312091T2 (de) |
| DK (1) | DK0677046T3 (de) |
| ES (1) | ES2105617T3 (de) |
| GB (1) | GB9300194D0 (de) |
| GR (1) | GR3024430T3 (de) |
| IL (1) | IL108259A (de) |
| PH (1) | PH31304A (de) |
| WO (1) | WO1994015928A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5900415A (en) * | 1994-11-07 | 1999-05-04 | Pfizer Inc. | Certain substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands |
| US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
| US6313126B1 (en) | 1999-01-07 | 2001-11-06 | American Home Products Corp | Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| US6200994B1 (en) | 1999-01-07 | 2001-03-13 | American Home Products Corp | 1,4-Disubstituted cyclohexane derivatives for the treatment of depression |
| DK1140919T3 (da) * | 1999-01-07 | 2002-12-30 | Wyeth Corp | 1,4-Disubstituerede cyclohexanderivater til behandling af depression |
| GB0316915D0 (en) | 2003-07-18 | 2003-08-20 | Glaxo Group Ltd | Compounds |
| AR047759A1 (es) * | 2003-09-26 | 2006-02-22 | Vertex Pharma | Derivados de fenil - piperazina como moduladores de receptores muscarnicos |
| JP4596792B2 (ja) * | 2004-02-24 | 2010-12-15 | あすか製薬株式会社 | ５−ｈｔ１ａ作動作用と５−ｈｔ３拮抗作用を併有する薬剤 |
| ATE530519T1 (de) | 2005-06-03 | 2011-11-15 | Abbott Lab | Cyclobutylaminderivate |
| US7576110B2 (en) | 2005-09-22 | 2009-08-18 | Abbott Laboratories | Benzothiazole cyclobutyl amine derivatives |
| US9108948B2 (en) | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
| AU2007260836B2 (en) | 2006-06-23 | 2012-11-15 | Abbvie Bahamas Ltd. | Cyclopropyl amine derivatives as histamin H3 receptor modulators |
| US9186353B2 (en) | 2009-04-27 | 2015-11-17 | Abbvie Inc. | Treatment of osteoarthritis pain |
| GB201017345D0 (en) * | 2010-10-14 | 2010-11-24 | Proximagen Ltd | Receptor antagonists |
| CA2856076C (en) | 2011-11-18 | 2020-02-25 | Heptares Therapeutics Limited | Muscarinic m1 receptor agonists |
| EP3277284B1 (de) | 2015-04-02 | 2020-08-05 | Proximagen, Llc | Neue behandlungen von krebs |
| GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| US10259787B2 (en) | 2016-10-14 | 2019-04-16 | Heptares Therapeutics Limited | Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists |
| GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3309370A (en) * | 1964-07-16 | 1967-03-14 | Miles Lab | Bicycloalkyl piperazine derivatives and process |
| US3354161A (en) * | 1964-07-16 | 1967-11-21 | Miles Lab | 8alpha-(4-phenyl-1-piperazyl)-4alpha, 5, 6, 7, 8alpha-hexahydro-4h-1-benzopyrans and process |
| NL7314672A (de) * | 1972-11-11 | 1974-05-14 | ||
| UST100505I4 (en) * | 1980-03-17 | 1981-04-07 | Triazolo[4,3-a]pyridin-3(2H)-ones | |
| US4975445A (en) * | 1989-12-06 | 1990-12-04 | Warner-Lambert Company | Substituted cyclohexenes as central nervous system agents |
| US5047406A (en) * | 1989-12-06 | 1991-09-10 | Warner-Lambert Co. | Substituted cyclohexanols as central nervous system agents |
| FR2689893A1 (fr) * | 1992-04-09 | 1993-10-15 | Rhone Poulenc Rorer Sa | Dérivés de diphényl-1,1 hydroxy-3 (sila)cyclopentane, leur préparation et les médicaments les contenant. |
-
1993
- 1993-01-06 GB GB939300194A patent/GB9300194D0/en active Pending
- 1993-12-24 WO PCT/GB1993/002661 patent/WO1994015928A1/en active IP Right Grant
- 1993-12-24 DK DK94902964.9T patent/DK0677046T3/da active
- 1993-12-24 EP EP94902964A patent/EP0677046B1/de not_active Expired - Lifetime
- 1993-12-24 JP JP6515782A patent/JPH08505381A/ja active Pending
- 1993-12-24 AT AT94902964T patent/ATE155133T1/de not_active IP Right Cessation
- 1993-12-24 ES ES94902964T patent/ES2105617T3/es not_active Expired - Lifetime
- 1993-12-24 DE DE69312091T patent/DE69312091T2/de not_active Expired - Fee Related
- 1993-12-24 AU AU57115/94A patent/AU5711594A/en not_active Abandoned
- 1993-12-24 US US08/436,413 patent/US5622951A/en not_active Expired - Lifetime
-
1994
- 1994-01-03 IL IL10825994A patent/IL108259A/en not_active IP Right Cessation
- 1994-01-05 PH PH47581A patent/PH31304A/en unknown
-
1997
- 1997-08-13 GR GR970402073T patent/GR3024430T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5622951A (en) | 1997-04-22 |
| EP0677046A1 (de) | 1995-10-18 |
| EP0677046B1 (de) | 1997-07-09 |
| JPH08505381A (ja) | 1996-06-11 |
| WO1994015928A1 (en) | 1994-07-21 |
| GB9300194D0 (en) | 1993-03-03 |
| ES2105617T3 (es) | 1997-10-16 |
| GR3024430T3 (en) | 1997-11-28 |
| PH31304A (en) | 1998-07-06 |
| IL108259A0 (en) | 1994-04-12 |
| DE69312091D1 (de) | 1997-08-14 |
| IL108259A (en) | 1998-09-24 |
| DE69312091T2 (de) | 1998-02-19 |
| AU5711594A (en) | 1994-08-15 |
| DK0677046T3 (da) | 1997-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69312091T2 (de) | Piperazinderivate als 5-ht antagonisten | |
| DE69327541T2 (de) | 4-arylmethyloxymethyl piperidine als tachykinin antagonisten | |
| ES2123756T3 (es) | Derivados de piperazina. | |
| DE69431471T2 (de) | Amidderivate als 5-HT1A-Liganden | |
| DE59304311D1 (de) | N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika | |
| DE69416311D1 (de) | Verwendung von cephem-derivaten als antimetastatische mittel | |
| ATE203022T1 (de) | 4-(6-fluor-1,2-benzisoxazolyl)-1-piperidinyl- propoxy-chromen-4-on-derivate,ihre herstellung und ihre verwendung in der behandlung von psychosen, schizophrenie und angstzuständen | |
| KR970706280A (ko) | 5-HT1A 길항제로서의 비사이클릭 카복스아미드(Bicyclic carboxamides as 5-HT1 antagonists) | |
| DE69403896D1 (de) | 4-amino-2-(hetero)aryl-butanamide verwenbar als 5-ht1a-antagonisten | |
| FI955707A (fi) | Indolijohdannaiset steroidi-5alfa-reduktaasin inhibiittoreina | |
| DK0651747T3 (da) | Carbostyrilderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |